Regulatory Response to Trading Volume Increase
Date and Nature of Query
Astec LifeSciences Limited responded to the National Stock Exchange of India Limited on 9th September, 2026 regarding Notice Ref. No. NSE/CM/Surveillance/17517 dated 8th September, 2026. The query concerned a significant increase in the trading volume of the company's security across exchanges in the recent past.
Company's Clarification on Trading Volume
The company stated that as a listed entity, it is conscious of its responsibility to disseminate information that could impact share prices. The company confirmed it has been promptly disclosing events or information required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Compliance Statement
Astec LifeSciences confirmed full compliance with disclosure requirements under both the Listing Regulations and the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The company explicitly stated that there are no developments requiring mandatory disclosure under these regulations.
Financial Results Clarification
The document does not contain any discussion or clarification regarding financial results, adjustments, or changes to previously reported figures.